Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Differentiated Thyroid Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Study leads
Jiaying Chen
Principal Investigator
Fudan University
Yu Wang
Principal Investigator
Fudan University